What Happens in Week 2 on Mounjaro — and What Most People Get Wrong

The biggest misconception: no weight lost by week 2 means Mounjaro isn't working

This is the belief most worth correcting. People arrive at week 2 expecting the same trajectory they read about in clinical summaries (20% body weight lost, life transformed) and then feel alarmed when the bathroom scales show barely a pound of movement. The SURMOUNT-1 trial, published in the New England Journal of Medicine, ran for 72 weeks. The striking results came from months of consistent treatment, not a fortnight.

At 2.5 mg, tirzepatide is doing something real: it is beginning to engage both the GLP-1 and GIP receptors involved in appetite signalling and gastric emptying. But the dose has been set deliberately low. The first pen's job is adjustment, not transformation. Your prescriber titrates upward over a structured schedule precisely because rushing the process tends to produce more side effects without faster results.

If you took your second dose this week and are asking yourself whether it is working, the more useful question is: has your appetite shifted even slightly? Many people in week 2 notice they feel full a little sooner, or that the urge to eat between meals has softened. Those are early signals the medicine is active. The weight will follow. Our page on how long Mounjaro takes to work covers the fuller picture of what timelines look like across the titration schedule.

What side effects are most common in week 2 of Mounjaro, and when do they ease?

Week 2 is often when GI side effects are at their most noticeable. Nausea is the most frequently reported, followed by changes in bowel habit, some people experience looser stools, others constipation, and both can occur in the same fortnight. Fatigue, a dull headache and mild indigestion are also common. The NHS tirzepatide page lists these as expected effects during the early weeks of treatment.

The reason they cluster at the start is physiological. Slowing gastric emptying is part of how the medicine works, food sits in the stomach longer, which reduces hunger but can also trigger nausea, particularly if meals are too large or too fatty. Most people find that eating smaller amounts, choosing lower-fat foods and staying well hydrated takes the edge off. Symptoms generally settle within days to a couple of weeks for most patients, though the experience varies.

Two things warrant prompt medical attention at any point, including week 2: severe, persistent stomach pain that extends toward the back (a potential sign of pancreatitis, flagged in MHRA guidance), and any signs of a serious allergic reaction. For anything milder (nausea, tiredness, a bit of dizziness) your aftercare team is the right first call. Do not adjust your dose or timing without speaking to your prescriber first.

If you are curious how the first and second weeks compare in terms of what to expect, reading about what happens during week one of Mounjaro covers what typically happens at the very start in more detail.

Practical things that actually make week 2 more manageable

A few adjustments most people find genuinely useful. Eat slowly, stop before you feel full, the satiety signal with tirzepatide can arrive a little behind schedule, so pausing mid-meal gives your body time to catch up. Protein at every meal helps preserve muscle mass and tends to sit more comfortably on a reduced appetite than heavy carbohydrates or rich sauces. Keep water close.

On injection day itself, rotating the site matters more than it might seem. Abdomen, thigh and upper arm are all licensed injection sites per the SmPC; using the same spot repeatedly increases the chance of a localised skin reaction. Room temperature is kinder on the injection than going straight from the fridge, letting the pen sit for a minute or two often makes it more comfortable.

If you are using a private service and your pen arrived this week: the DPD tracking notification, the plain unbranded box, the KwikPen inside, that is the standard experience for people using a GPhC-registered online pharmacy with a proper cold-chain dispatch. If anything looked unusual about the packaging or seal when your pen arrived, that is worth raising with your pharmacy immediately. The MHRA has flagged counterfeit pens as a real risk when medicines are sourced outside the licensed supply chain.

Week 3 is where many people report their appetite suppression becoming more consistent. Our week 3 guide covers what that shift typically looks like and what to watch for around dose increases.

When no weight loss in week 2 is genuinely worth discussing

Not seeing weight change by day 14 is normal. Not feeling any appetite change at all by the end of week 2 is worth mentioning to your prescriber, not because it signals failure, but because your clinical team needs the full picture. Some people find the 2.5 mg dose barely perceptible; others feel it clearly. Both are within the expected range.

What matters more at this stage is whether side effects are tolerable and whether you are managing to maintain the lifestyle changes (reduced-calorie eating, regular movement) that work alongside the medicine. Mounjaro is not a standalone treatment. The clinical trials were conducted alongside dietary and activity support, and that context shapes the results. If you want a broader view of how tirzepatide works as a treatment, including eligibility criteria and what the full titration journey looks like, that page sets out the complete picture.

If the scale genuinely has not moved after several more weeks, there is a dedicated guide to week 2 with no weight loss that addresses the specific reasons that can happen and when it is worth acting on. For those thinking further ahead, the week 4 guide covers what to expect as you approach the first potential dose review.

Mounjaro is a prescription-only medicine. Every repeat at nume goes through a fresh clinical review, a real prescriber reads your update, not a system. If you have not yet started and want to understand whether treatment is right for you, check your eligibility with a free consultation.